Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
Latest
Popular

Editor's choice for January 2016

Prof Gordon McVie - ecancer Editor
Editor's choice for January 2016 ( Prof Gordon McVie - ecancer Editor )
2 Feb 2016

Entinostat and high-dose Interleukin 2 in renal cell carcinoma patients

Prof Roberto Pili - Indiana University, Indianapolis, USA
Entinostat and high-dose Interleukin 2 in renal cell carcinoma patients ( Prof Roberto Pili - Indiana University, Indianapolis, USA )
9 Jan 2016

Gemcitabine plus cisplatin plus ipilimumab for metastatic urothelial cancer

Prof Matthew Galsky - The Mount Sinai Hospital, New York, USA
Gemcitabine plus cisplatin plus ipilimumab for metastatic urothelial cancer ( Prof Matthew Galsky - The Mount Sinai Hospital, New York, USA )
8 Jan 2016

Avelumab for metastatic urothelial carcinoma: JAVELIN trial

Dr Andrea Apolo - National Cancer Institute, Maryland, USA
Avelumab for metastatic urothelial carcinoma: JAVELIN trial ( Dr Andrea Apolo - National Cancer Institute, Maryland, USA )
8 Jan 2016

Integrated genomic correlates of response to PD-1 inhibitor nivolumab in mRCC

Dr Guillermo de Velasco - Dana-Farber Cancer Institute, Boston, USA
Integrated genomic correlates of response to PD-1 inhibitor nivolumab in mRCC ( Dr Guillermo de Velasco - Dana-Farber Cancer Institute, Boston, USA )
8 Jan 2016

Impact of metformin on outcomes for metastatic renal cell carcinoma

Dr Rana McKay - Dana-Farber Cancer Institute, Boston, USA
Impact of metformin on outcomes for metastatic renal cell carcinoma ( Dr Rana McKay - Dana-Farber Cancer Institute, Boston, USA )
8 Jan 2016

ASCO GU 2016: Highlights

Dr Toni Choueiri - Dana Farber Cancer Institute, Boston, USA
ASCO GU 2016: Highlights ( Dr Toni Choueiri - Dana Farber Cancer Institute, Boston, USA )
8 Jan 2016

Atezolizumab for platinum-treated locally advanced or metastatic urothelial carcinoma

Dr Jean Hoffman-Censits - Kimmel Cancer Center, Philadelphia, USA
Atezolizumab for platinum-treated locally advanced or metastatic urothelial carcinoma ( Dr Jean Hoffman-Censits - Kimmel Cancer Center, Philadelphia, USA )
8 Jan 2016

Brentuximab vedotin as salvage therapy for men with relapsed germ-cell tumours

Dr Andrea Necchi - Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
Brentuximab vedotin as salvage therapy for men with relapsed germ-cell tumours ( Dr Andrea Necchi - Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy )
7 Jan 2016

Survival outcomes from the CALGB 40603 study in triple-negative breast cancer

Dr William Sikov - Women & Infants Hospital of Rhode Island, Providence, USA
Survival outcomes from the CALGB 40603 study in triple-negative breast cancer ( Dr William Sikov - Women & Infants Hospital of Rhode Island, Providence, USA )
17 Dec 2015

TH3RESA: T-DM1 improves overall survival in previously treated advanced cancer patients

Prof Hans Wildiers - University Hospital of Leuven, Leuven, Belgium
TH3RESA: T-DM1 improves overall survival in previously treated advanced cancer patients ( Prof Hans Wildiers - University Hospital of Leuven, Leuven, Belgium )
17 Dec 2015

NSABP FB-7: Neoadjuvant therapy with neratinib plus trastuzumab in locally advanced HER2-positive breast cancer

Dr Samuel Jacobs - NSABP Foundation, Pittsburgh, USA
NSABP FB-7: Neoadjuvant therapy with neratinib plus trastuzumab in locally advanced HER2-positive breast cancer ( Dr Samuel Jacobs - NSABP Foundation, Pittsburgh, USA )
17 Dec 2015

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation